https://www.selleckchem.com/pr....oducts/Dihydroartemi
3%) and 183 trabeculectomy eyes (43.7%). In this cohort, there was no significant failure risk difference (12.3% for tube eyes and 16.4% for trabeculectomy eyes, P=0.231). Comparing the studies, there was a significantly greater risk of failure in the TVT IRIS Registry tube eyes than in the TVT RCT tube eyes (3.8%; P .001). Reasons for treatment failure included reoperations for glaucoma (none in the TVT RCT at 1 year). Our results were different from those in the TVT RCT. Possible reasons include non-Baerveldt tubes
Synes godt om
Kommentar
Del
